Free Access
| Issue |
J Extra Corpor Technol
Volume 40, Number 2, June 2008
|
|
|---|---|---|
| Page(s) | 123 - 126 | |
| DOI | https://doi.org/10.1051/ject/200840123 | |
| Published online | 15 June 2008 | |
- Wittenstein B, Ng C, Ravn H, Goldman A. Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery. Pediatr Crit Care Med. 2005;6:473–6. [CrossRef] [PubMed] [Google Scholar]
- Murkin JM. A novel hemostatic agent: the potential role of recom-binant activated factor VII (rFVIIa) in anesthetic practice. Can J Anesth. 2002;49:521–6. [Google Scholar]
- Dominguez TE, Mitchell M, Friess SH, et al. Use of recombinant factor VIIa for refractory hemorrhage during extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2005;6:348–51. [CrossRef] [PubMed] [Google Scholar]
- Diprose P, Herbertson MJ, Shaughnessy DO, Gill RS. Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study. Br J Anesth. 2005;95:596–602. [CrossRef] [Google Scholar]
- Brose S, Sirbu H, Engel M, Kuhlen R, Autschbach R. Successful use of recombinant factor VIIa in a patient with intractable bleeding during extra-corporeal membrane oxygenation. Thorac Cardiovasc Surg. 2005;53:389–90. [CrossRef] [PubMed] [Google Scholar]
- Agarwal HS, Bennett JE, Churchwell KB, et al. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. Ann Thorac Surg. 2007;84:161–9. [CrossRef] [Google Scholar]
- Bui JD, Despotis GD, Trulock EP, Patterson GA, Goodnough LT. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J Thorac Cardiovasc Surg. 2002;124:852–4. [CrossRef] [Google Scholar]
- O’Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM. Throm-boembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA. 2006;295:293–8. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.